EP1216686B1 - Gel-crèmes de type émulsion h/e contenant au moins un copolymère acryloyl diméthyltaurate d'ammonium/ vinyl pyrrolidone - Google Patents

Gel-crèmes de type émulsion h/e contenant au moins un copolymère acryloyl diméthyltaurate d'ammonium/ vinyl pyrrolidone Download PDF

Info

Publication number
EP1216686B1
EP1216686B1 EP01130560A EP01130560A EP1216686B1 EP 1216686 B1 EP1216686 B1 EP 1216686B1 EP 01130560 A EP01130560 A EP 01130560A EP 01130560 A EP01130560 A EP 01130560A EP 1216686 B1 EP1216686 B1 EP 1216686B1
Authority
EP
European Patent Office
Prior art keywords
polyethylene glycol
acid
red
ether
der
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01130560A
Other languages
German (de)
English (en)
Other versions
EP1216686A3 (fr
EP1216686A2 (fr
Inventor
Ghita Dr. Lanzendörfer
Jens Nielsen
Birgit Hargens
Rainer Kröpke
Heidi Riedel
Stephanie Von Thaden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clariant International Ltd
Original Assignee
Clariant International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clariant International Ltd filed Critical Clariant International Ltd
Publication of EP1216686A2 publication Critical patent/EP1216686A2/fr
Publication of EP1216686A3 publication Critical patent/EP1216686A3/fr
Application granted granted Critical
Publication of EP1216686B1 publication Critical patent/EP1216686B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to oil-in-water type cosmetic and dermatological preparations, processes for their preparation and their use for cosmetic and medical purposes.
  • Human skin as the largest human organ, performs many vital functions. With an average of about 2 m 2 surface in the adult, it plays a prominent role as a protective and sensory organ. The task of this organ is to mediate and ward off mechanical, thermal, actinic, chemical and biological stimuli. In addition, it plays an important role as regulatory and target organ in human metabolism.
  • Cosmetic skincare is primarily understood to strengthen or restore the natural function of the skin as a barrier against environmental influences (eg dirt, chemicals, microorganisms) and against the loss of endogenous substances (eg water, natural fats, electrolytes) and their horny layer to assist in the event of damage occurring in their natural regeneration capacity.
  • environmental influences eg dirt, chemicals, microorganisms
  • endogenous substances eg water, natural fats, electrolytes
  • the aim of skin care is also to compensate for the daily loss of fat and water loss of the skin. This is especially important when the natural Regeneration capacity is insufficient.
  • skin care products to protect against environmental influences, especially from the sun and wind, and delay the aging of the skin.
  • Medical topical compositions typically contain one or more drugs in effective concentration.
  • Emulsions are generally understood to mean heterogeneous systems which consist of two liquids that are immiscible or only slightly miscible with one another, which are usually referred to as phases.
  • one of the two liquids is dispersed in the form of very fine droplets in the other liquid.
  • O / W emulsion oil-in-water emulsion
  • the basic character of an O / W emulsion is characterized by the water.
  • a water-in-oil emulsion (W / O emulsion, eg butter) is the reverse principle, with the basic character being determined by the oil.
  • Gel creams are particularly light products with a low emulsifier and lipid content. They are characterized by the fact that they can be easily distributed on the skin and convey a feeling of freshness. After the product application, little or no residue should remain on the skin. Gel creams usually contain a relatively high proportion of hydrophilic thickeners (eg carbopols, xanthan gum, hydroxyethyl cellulose), since the thickener or the thickener system is in the outer phase, it has a significant influence on the sensory properties of the product either do not spread easily, give no freshness feeling or leave too sticky residue on the skin.
  • hydrophilic thickeners eg carbopols, xanthan gum, hydroxyethyl cellulose
  • ammoniumacryloyldimethyltaurate or vinylpyrrolidone copolymer (s) have the empirical formula [C 7 H 16 N 2 SO 4 ] n [C 6 H 9 NO] m , corresponding to a statistical structure as follows Preferred species for the purposes of the present invention are filed in the Chemical Abstracts under the filing numbers 58374-69-9, 13162-05-5 and 88-12-0 and available under the trade name Aristoflex® AVC from Clariant GmbH.
  • the lipid content of the preparations obtainable according to the invention can advantageously be varied from 0.5% by weight to 20% by weight, preferably from 5 to 10% by weight, with equally favorable results being achieved.
  • lipid-free there is no emulsion but a system which should be most appropriately referred to as emulsifier gel.
  • Preparations according to the invention contain up to 7.5% by weight of a lipid phase and represent O / W emulsions. Particularly advantageously, preparations according to the invention contain up to 6% by weight of a lipid phase. Particularly preferred preparations according to the invention contain 2 to 4 wt .-% of a lipid phase, in particular about 3 wt .-%, each based on the total weight of the preparations.
  • the oil phase of the emulsions of the present invention is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
  • ester oils can then be advantageously selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2 Octyldodecyl palmitate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and synthetic, semi-synthetic and natural mixtures of such esters, eg Jojoba oil.
  • the oil phase can be advantageously selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and the fatty acid triglycerides, in particular the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids of a chain length of 8 to 24, in particular 12 to 18 carbon atoms.
  • the fatty acid triglycerides can be advantageously selected from the group of synthetic, semi-synthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
  • any mixtures of such oil and wax components are also advantageous to use in the context of the present invention. It may also be advantageous, if appropriate, to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
  • the oil phase is advantageously selected from the group 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C 12-15 -alkyl benzoate, caprylic-capric triglyceride, dicaprylyl ether.
  • Particularly advantageous are mixtures of C 12-15 -alkyl benzoate and 2-ethylhexyl isostearate, mixtures of C 12-15 -alkyl benzoate and isotridecyl isononanoate and mixtures of C 12-15 -alkyl benzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate.
  • hydrocarbons paraffin oil, squalane and squalene are to be used advantageously in the context of the present invention.
  • the oil phase may further comprise a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or silicone oils.
  • Such silicones or silicone oils may be present as monomers, which are typically characterized by structural elements, as follows:
  • linear silicones having several siloxy units which are advantageously used according to the invention, they are generally characterized by structural elements as follows: wherein the silicon atoms can be substituted with identical or different alkyl radicals and / or aryl radicals, which are here generalized by the radicals R 1 - R 4 (to say that the number of different radicals is not necessarily limited to 4).
  • m can assume values of 2 - 200,000.
  • Cyclic silicones which are advantageously used in accordance with the invention are generally characterized by structural elements as follows wherein the silicon atoms can be substituted with identical or different alkyl radicals and / or aryl radicals, which are here generalized by the radicals R 1 - R 4 (to say that the number of different radicals is not necessarily limited to 4).
  • n can assume values of 3/2 to 20. Broken values for n take into account that odd numbers of siloxyl groups may be present in the cycle.
  • cyclomethicone e.g., decamethylcyclopentasiloxane
  • silicone oils are also advantageous for the purposes of the present invention, for example undecamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane), cetyl dimethicone, behenoxydimethicone.
  • silicone oils of similar constitution as the compounds described above, whose organic side chains are derivatized, for example polyethoxylated and / or polypropoxylated.
  • silicone oils of similar constitution as the compounds described above, whose organic side chains are derivatized, for example polyethoxylated and / or polypropoxylated.
  • These include, for example, polysiloxane-polyalkyl-polyether copolymers such as the cetyl-dimethicone copolyol which (cetyl dimethicone copolyol (and) polyglyceryl-4-isostearate (and) hexyl laurate)
  • mixtures of cyclomethicone and isotridecyl isononanoate, cyclomethicone and 2-ethylhexyl isostearate are particularly advantageous.
  • the aqueous phase of the preparations according to the invention advantageously contains alcohols, diols or polyols of low C number, and also their ethers, preferably Ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, furthermore lower C-number alcohols, eg ethanol, isopropanol, 1,2-propanediol, Glycerol and in particular one or more thickeners, which or which can be advantageously selected from the group of silica, aluminum silicates.
  • ethers preferably Ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glyco
  • Preparations according to the invention present as emulsions advantageously contain one or more hydrocolloids.
  • hydrocolloids can be advantageously selected from the group of gums, polysaccharides, cellulose derivatives, phyllosilicates, polyacrylates and / or other polymers.
  • the gums include plant or tree juices that harden in the air and form resins or extracts from aquatic plants.
  • gum arabic, locust bean gum, tragacanth, karaya, guar gum, pectin, gellan gum, carrageenan, agar, algins, chondrus, xanthan gum can be selected from this group.
  • derivatized gums such as e.g. Hydroxypropyl guar (Jaguar® HP 8).
  • polysaccharides and derivatives are e.g. Hyaluronic acid, chitin and chitosan, chondroitin sulphates, starch and starch derivatives.
  • cellulose derivatives are e.g. Methylcellulose, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose.
  • layered silicates are naturally occurring and synthetic clays such as e.g. Montmorillonite, bentonite, hectorite, laponite, magnesium aluminum silicates such as Veegum®. These may be used as such or in modified form as e.g. Stearylalkonium hectorites.
  • polyacrylates are e.g. Carbopol types from Goodrich (Carbopol 980, 981, 1382, 5984, 2984, EDT 2001 or Pemulen TR2).
  • polymers e.g. Polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols.
  • Preparations according to the invention present as emulsions contain one or more emulsifiers. These emulsifiers can be advantageously selected from the group of nonionic, anionic, cationic or amphoteric emulsifiers.
  • emulsifiers which include beeswax, wool wax, lecithin and sterols.
  • the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifiers used are selected particularly advantageously from the group of substances having HLB values of 11-18, very particularly advantageously having HLB values of 14.5-15, 5, provided that the O / W emulsifiers have saturated radicals R and R '. If the O / W emulsifiers have unsaturated radicals R and / or R ', or if isoalkyl derivatives are present, the preferred HLB value of such emulsifiers may also be lower or higher.
  • fatty alcohol ethoxylates from the group of ethoxylated stearyl alcohols, cetyl alcohols, cetylstearyl alcohols (cetearyl alcohols). Particularly preferred are:
  • Polyethylene glycol (12) lauryl ether (Laureth-12), polyethylene glycol (12) isolauryl ether (Isolaureth-12).
  • the sodium laureth-11-carboxylate can be advantageously used.
  • sodium laureth 1-4 sulfate can be advantageously used.
  • polyethylene glycol (30) cholesteryl ether can be advantageously used. Also polyethylene glycol (25) soybean oil has been proven.
  • the Polyethylenglycolglycerinfettklander from the group polyethylene glycol (20) glyceryl laurate, polyethylene glycol (21) glyceryl laurate, polyethylene glycol (22) glyceryl laurate, polyethylene glycol (23) glyceryl laurate, polyethylene glycol (6) glyceryl caprate / caprinate, polyethylene glycol (20) glyceryl oleate, polyethylene glycol (20) glyceryl isostearate, polyethylene glycol (18) glyceryl oleate / cocoate.
  • sorbitan esters from the group of polyethylene glycol (20) sorbitan monolaurate, polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) sorbitan monoisostearate, polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate.
  • W / O emulsifiers can be used: fatty alcohols having 8 to 30 carbon atoms, monoglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids of a chain length of 8 to 24, in particular 12- 18 C atoms, diglycerol saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12-18, carbon atoms, monoglycerol ethers of saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 8 to 24, in particular 12-18 C Atoms, diglycerol ethers of saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 8 to 24, in particular 12- 18 C-atoms, propylene glycol esters of saturated and / or unsaturated, branched and / or unbranched alkan
  • W / O emulsifiers are glyceryl monostearate, glyceryl, glyceryl monomyristate, glyceryl, diglyceryl monostearate, Diglycerylmonoisostearat, propylene glycol, propylene glycol monoisostearate, propylene glycol monocaprylate, propylene glycol, sorbitan, sorbitan, sorbitan, Sorbitanmonoisooleat, sucrose, cetyl alcohol, stearyl, arachidyl, behenyl, Isobehenylalkohol, selachyl, Chimyl alcohol, polyethylene glycol (2) stearyl ether (steareth-2), glyceryl monolaurate, glyceryl monocaprinate, glyceryl monocaprylate.
  • the gel creams according to the invention may contain dyes and / or color pigments.
  • the dyes and pigments can be selected from the corresponding positive list of the Cosmetics Regulation or EC List of cosmetic colorants. In most cases, they are identical to the food-approved dyes.
  • advantageous color pigments are titanium dioxide, mica, iron oxides (eg Fe 2 O 3 , Fe 3 O 4 , FeO (OH)) and / or tin oxide.
  • Advantageous dyes are, for example, carmine, Berlin blue, chrome oxide green, ultramarine blue and / or manganese violet. It is particularly advantageous to choose the dyes and / or color pigments from the following list.
  • CIN Color Index numbers
  • the dye 2,4-dihydroxyazobenzene, 1- (2'-chloro-4'-nitro-1'-phenylazo) -2-hydroxynaphthalene, Ceresrot, 2- (4-sulfo-1-naphthylazo) -1-naphthol-4-sulfonic acid, calcium salt of 2-hydroxy-1,2'-azonaphthalene-1'-sulfonic acid, calcium and barium salts of 1- (2-sulfonic acid) 4-methyl-1-phenylazo) -2-naphthylcarboxylic acid, calcium salt of 1- (2-sulfo-1-naphthylazo) -2-hydroxynaphthalene-3-carboxylic acid, aluminum salt of 1- (4-sulfo-1-phenylazo) -2 -naphthol-6-sulfonic acid, aluminum salt of 1- (4-sulfo-1-naph
  • oil-soluble natural dyes such as paprika extracts, ⁇ -carotene or cochineal.
  • pearlescent pigments are, for example, pulverulent pigments or castor oil dispersions of bismuth oxychloride and / or titanium dioxide and also bismuth oxychloride and / or titanium dioxide on mica.
  • vorteihaft z For example, listed under the CIN 77163 luster pigment.
  • pearlescent pigment types based on mica / metal oxide group Occupancy / layer thickness colour
  • Silver-white pearlescent pigments TiO 2 : 40-60 nm silver interference pigments TiO 2 : 60-80 nm yellow TiO 2 : 80-100 nm red
  • TiO 2 100-140 nm blue
  • TiO 2 120-160 nm
  • Color Luster Pigments Fe 2 O 3 bronze Fe 2 O 3 copper Fe 2 O 3 red Fe 2 O 3 rotviolett Fe 2 O 3 Red Green Fe 2 O 3 black combination pigments
  • pearlescent pigments available from Merck under the trade names Timiron, Colorona or Dichrona.
  • pearlescent pigments which are advantageous in the context of the present invention are obtainable in numerous ways known per se.
  • other substrates except mica can be coated with other metal oxides such.
  • silica and the like As silica and the like.
  • iron pearlescent pigments which are prepared without the use of mica.
  • Such pigments are z. B. under the trade name Sicopearl copper 1000 available from BASF.
  • effect pigments which are available under the trade name Metasomes Standard / Glitter in various colors (yellow, red, green, blue) from Flora Tech.
  • the glitter particles are present in mixtures with various auxiliaries and dyes (such as the dyes with the Color Index (Cl) numbers 19140, 77007, 77289, 77491).
  • the dyes and pigments can be present both individually and in a mixture and can be mutually coated with one another, wherein different coating thicknesses generally cause different color effects.
  • the total amount of dyes and coloring pigments is advantageously from the range of z. B. 0.1 wt .-% to 30 wt .-%, preferably from 0.5 to 15 wt .-%, in particular from 1.0 to 10 wt .-%, each based on the total weight of the preparations.
  • Gelcrußs invention can be used as eyeshadow.
  • antioxidants are used as additives or active ingredients.
  • the preparations advantageously contain one or more antioxidants.
  • antioxidants all suitable or customary for cosmetic and / or dermatological applications or conventional antioxidants can be used.
  • the antioxidants are selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-camosine, L-carnosine and their derivatives (eg anserine), carotenoids, carotenes (eg ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (eg thioredoxin, Glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propy
  • oil-soluble antioxidants can be used.
  • formulations of the present invention are very good vehicles for cosmetic or dermatological agents into the skin, with preferred agents being antioxidants which can protect the skin from oxidative stress.
  • preferred agents are antioxidants which can protect the skin from oxidative stress.
  • Preferred antioxidants are vitamin E and its derivatives as well as vitamin A and its derivatives.
  • the amount of antioxidants (one or more compounds) in the preparations is preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20% by weight, in particular from 1 to 10% by weight, based on the total weight of the preparation ,
  • vitamin E and / or its derivatives are the antioxidant (s), it is advantageous to choose their respective concentrations from the range of 0.001-10% by weight, based on the total weight of the formulation.
  • vitamin A or vitamin A derivatives, or carotenes or derivatives thereof are the antioxidant (s), it is advantageous if their respective concentrations are within the range of 0.001-10% by weight, based on the total weight of the formulation, of to choose.
  • the cosmetic and dermatological preparations according to the invention may accordingly also contain cosmetic adjuvants conventionally used in such preparations, for example bodying agents, stabilizers, fillers, preservatives, perfumes, substances for preventing foaming, dyes, pigments having a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances, anti-inflammatory substances, additional active ingredients such as vitamins or proteins, light stabilizers, Insect repellents, bactericides, virucides, water, salts, antimicrobial, proteolytic or keratolytic substances, medicaments or other conventional ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, organic solvents or electrolytes.
  • cosmetic adjuvants conventionally used in such preparations, for example bodying agents, stabilizers, fillers, preservatives, perfumes, substances for preventing foaming, dyes, pigments having a coloring effect, thickeners, surface
  • the latter can be selected, for example, from the group of salts with the following anions: chlorides, furthermore inorganic oxo element anions, of these in particular sulfates, carbonates, phosphates, borates and aluminates.
  • organic anion-based electrolytes are advantageous, e.g. Lactates, acetates, benzoates, propionates, tartrates, citrates, amino acids, ethylenediaminetetraacetic acid and its salts and others.
  • Ammonium, alkylammonium, alkali metal, alkaline earth metal, magnesium, iron or zinc ions are preferably used as cations of the salts.
  • Particularly preferred are potassium chloride, common salt, magnesium sulfate, zinc sulfate and mixtures thereof.
  • the gel creams according to the invention can serve as a basis for cosmetic or dermatological formulations. These may be composed as usual and serve, for example, for the treatment and care of the skin and / or the hair, as a lip care product, as a Deo etc and as make-up or make-up removal product in the decorative cosmetics or as a sunscreen preparation.
  • the cosmetic and dermatological preparations according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics or dermatological agents.
  • cosmetic or topical dermatological compositions for the purposes of the present invention, depending on their structure, can be used, for example, as skin protection cream, cleansing milk, sunscreen lotion, nutrient cream, day cream or night cream, etc. It may be possible and advantageous to use the compositions according to the invention as a basis for pharmaceutical formulations use.
  • compositions according to the invention can be present for example as preparations which can be sprayed from aerosol containers, squeeze bottles or by a pumping device or in the form of a liquid composition which can be applied by means of roll-on devices, but also in the form of an emulsion which can be applied from normal bottles and containers.
  • Suitable propellants for sprayable from aerosol containers cosmetic or dermatological preparations in the context of the present invention, the usual known volatile, liquefied propellants, such as hydrocarbons (propane, butane, isobutane) are suitable, which can be used alone or in mixture with each other. Also, compressed air is advantageous to use.
  • hydrocarbons propane, butane, isobutane
  • these preferably additionally contain at least one UV-A filter substance and / or at least one UV-B filter substance and / or at least one inorganic pigment.
  • UV protectants as well as antioxidants and, if desired, preservatives, provide effective protection of the preparations themselves against spoilage.
  • preparations according to the invention may also contain substances which absorb UV radiation in the UVB range, the total amount of filter substances being e.g. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 10 wt .-%, in particular 1.0 to 6.0 wt .-%, based on the total weight of the preparations to cosmetic preparations for To provide the hair or the skin against the entire range of ultraviolet radiation. They can also serve as a sunscreen for hair or skin.
  • UVB filters which can be used in combination with the active compound combinations according to the invention should of course not be limiting.
  • UVA filters which have hitherto usually been present in cosmetic preparations.
  • these substances are preferably derivatives of dibenzoylmethane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione and 1-phenyl-3- (4 ' -isopropylphenyl) propane-1,3-dione.
  • Cosmetic and dermatological preparations according to the invention may also contain inorganic pigments which are commonly used in cosmetics for protecting the skin from UV rays. These are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, as well as modifications in which the oxides are the active agents. Particular preference is given to pigments based on titanium dioxide.
  • Example 1 hydrodispersion gel: Wt .-% PEG-8 (polythylene glycol 400) 5.00 ethanol 10.00 Aristoflex AVC 0.70 Triglyceride, liquid 1.50 glycerin 5.00 panthenol 0.50 tocopherol 0.50 Perfume, preservatives, NaOH, dyes, antioxidants etc.
  • Example 2 Hydodispersion Gel: % By weight xanthan gum 0.20 Aristoflex AVC 1.00 glycerin 5.00 1.3 butylene glycol 2.00 dimethicone 3.00 isopropyl palmitate 1.50 Perfume, preservatives, NaOH, dyes, antioxidants, pigments etc.
  • Example 3 % By weight sucrose stearate 1.00 Cetearylalcohol 0.50 PEG-5 soybean oil 2.00 tocopherol 1.00 Aristoflex AVC 1.00 glycerin 3.00 EDTA 0.50 Antioxidants, preservatives, neutralizing agents, perfume, dyes, pigments qs water ad 100.00
  • Example 4 % By weight glycerol 2.00 PEG-40 glyceryl stearate 0.50 Aristoflex AVC 1.00 magnesium aluminum silicate 0.30 glycerin 5.00 1.3 butylene glycol 2.00 panthenol 2.50 Perfume, preservatives, NaOH, complexing agents, dyes, antioxidants, pigments etc.
  • Example 5 % By weight glyceryl stearate 1.50 cetyl alcohol 0.50 jojoba oil 2.00 Aristoflex AVC 0.50 chitosan 0.50 Lactic acid (90%) 0.30 glycerin 5.00 Perfume, preservatives, NaOH, dyes, antioxidants, pigments etc. qs water ad 100.00
  • Example 6 % By weight Polyglyceryl-3 methylglucose 2.00 sorbitan 0.50 glycerin 3.00 C 12-15 alkyl benzoates 5.00 Caprylic / capric 3.00 Aristoflex AVC 0.50 Perfume, preservatives, NaOH, dyes, antioxidants, pigments etc.
  • Example 7 % By weight decyl glucoside 1.00 glyceryl 1.50 dimethicone 2.00 Triceteareth-4 phosphates 0.70 panthenol 1.50 Isopropyl palmitate 1.00 Aristoflex AVC 1.00 Perfume, preservatives, NaOH, dyes, antioxidants, pigments etc.
  • Example 8 Wt .-% stearyl 2.00 Caprylic / capric 2.00 paraffin oil 2.00 octyldodecanol 3.00 glycerin 3.00 Acrylates / C 10-30 alkyl acrylate crosspolymer 0.15 Aristoflex AVC 0.20 tocopheryl acetate 0.50 Perfume, preservatives, NaOH, dyes, antioxidants, pigments etc. qs Water demineralized, ad 100.00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Claims (4)

  1. Crème gel cosmétique ou dermatologique du type huile dans l'eau, comprenant :
    (i) jusqu'à 90 % en poids d'une phase aqueuse,
    (ii) de 2 à 7,5 % en poids d'une phase lipidique, par rapport au poids total de la préparation,
    (iii) jusqu'à 5 % en poids d'un ou plusieurs émulsifiants,
    (iv) comprenant en outre jusqu'à 5 % en poids d'un ou plusieurs copolymères d'acryloyldiméthyltaurate d'ammonium/vinylpyrrolidone.
  2. Crème gel selon la revendication 1, caractérisé en ce qu'il contient un ou plusieurs colorants et/ou pigments colorants.
  3. Crème gel selon la revendication 2, caractérisé en ce que la quantité totale des colorants et des pigments colorants est choisie dans la plage de, par exemple, 0,1 % en poids à 30 % en poids, de préférence de 0,5 à 15 % en poids, en particulier de 1,0 à 10 % en poids, par rapport au poids total de la préparation.
  4. Utilisation de la crème gel selon la revendication 2 comme ombre à paupière.
EP01130560A 2000-12-23 2001-12-21 Gel-crèmes de type émulsion h/e contenant au moins un copolymère acryloyl diméthyltaurate d'ammonium/ vinyl pyrrolidone Expired - Lifetime EP1216686B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10065047A DE10065047A1 (de) 2000-12-23 2000-12-23 Gelcèmes in Form von O/W-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumaryloyldimethyltaurat/vinylpyrrolidoncopolymeren
DE10065047 2000-12-23

Publications (3)

Publication Number Publication Date
EP1216686A2 EP1216686A2 (fr) 2002-06-26
EP1216686A3 EP1216686A3 (fr) 2002-07-17
EP1216686B1 true EP1216686B1 (fr) 2008-02-20

Family

ID=7669007

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01130560A Expired - Lifetime EP1216686B1 (fr) 2000-12-23 2001-12-21 Gel-crèmes de type émulsion h/e contenant au moins un copolymère acryloyl diméthyltaurate d'ammonium/ vinyl pyrrolidone

Country Status (4)

Country Link
US (1) US6620420B2 (fr)
EP (1) EP1216686B1 (fr)
JP (1) JP3793798B2 (fr)
DE (2) DE10065047A1 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10065045A1 (de) * 2000-12-23 2002-07-04 Beiersdorf Ag W/O-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumacryloyldimethyltaurat/Vinylpyrrolidoncopolymeren
DE10065046A1 (de) * 2000-12-23 2002-07-04 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Ammonium acryloyldimethyltaurat/Vinylpyrrolidoncopolymeren
JP2002226334A (ja) * 2001-01-30 2002-08-14 Arimino Kagaku Kk 頭髪用酸性染毛料組成物
DE10116497B4 (de) * 2001-04-03 2004-08-12 Faber-Castell Ag Flüssigkeit zur Lippenpflege oder Lippenfärbung
US20030118620A1 (en) * 2001-09-12 2003-06-26 Unilever Home & Personal Care Usa, Division Of Conopco Inc. Thickener system for cosmetic compositions
US6986895B2 (en) 2001-09-12 2006-01-17 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Thickened cosmetic compositions
DE10163500A1 (de) * 2001-12-21 2002-12-19 Wella Ag Versprühbare Haargele
US20040234478A1 (en) * 2003-05-08 2004-11-25 The Procter & Gamble Company Personal care compositions containing a silicone elastomer
DE10357452A1 (de) * 2003-12-03 2005-06-30 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt an Licochalcon A oder einem Extrakt aus Radix Glycyrrhizae inflatae, enthaltend Licochalcon A, und organischen Verdicker
DE102004003436A1 (de) * 2004-01-21 2005-08-11 Beiersdorf Ag Dünnflüssige O/W-Emulsion II
WO2005070384A1 (fr) * 2004-01-23 2005-08-04 Unilever Plc Composition cosmetique pigmentee preparee a base de taurate, a effet lumiere legerement mate
US7695726B2 (en) * 2004-01-23 2010-04-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Pigmented cosmetic composition exhibiting radiance with soft focus
JP2005320263A (ja) * 2004-05-06 2005-11-17 Shiseido Co Ltd 水中油型乳化皮膚化粧料
US20050249684A1 (en) * 2004-05-07 2005-11-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus
DE102004042848A1 (de) * 2004-09-04 2006-03-09 Wella Ag Haarbehandlungsmittel mit Gehalt an einer Polymerkombination
DE102004057406A1 (de) * 2004-11-26 2006-06-01 Henkel Kgaa Öl-in-Wasser Emulsionen
US20060135383A1 (en) * 2004-12-17 2006-06-22 Cossa Anthony J Cleansing compositions comprising polymeric emulsifiers and methods of using same
US8147853B2 (en) 2005-02-15 2012-04-03 The Procter & Gamble Company Personal care compositions containing hydrophobically modified non-platelet particles
DE102005023638A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt an Glucosylglyceriden und einem oder mehreren Acrylamidomethylpropylsulfonsäure-Polymeren
JP2006335925A (ja) * 2005-06-03 2006-12-14 Jsr Corp スルホン酸基含有ポリマー、及びその製造方法、並びにポリマー組成物
DE102005038069A1 (de) 2005-08-10 2007-03-08 Henkel Kgaa Öl-in-Wasser Emulsionen
US20070092458A1 (en) * 2005-10-24 2007-04-26 Librizzi Joseph J Compositions comprising polymeric emulsifiers and methods of using the same
US20070092457A1 (en) * 2005-10-24 2007-04-26 Librizzi Joseph J Compositions comprising polymeric emulsifiers and methods of using the same
EP1921746B2 (fr) * 2006-11-08 2013-06-12 Siemens Audiologische Technik GmbH Circuit électronique pour l'ajustage de la puissance de sortie et / ou de la réponse en fréquence d'un amplificateur pour une prothèse auditive
FR2908647B1 (fr) * 2006-11-21 2013-11-01 Oreal Mascara comprenant moins un derive d'acide citrique et/ou un de ses sels
EP1920757B1 (fr) * 2006-11-10 2016-05-11 L'Oréal Composition cosmétique comprenant un dérivé d'acide citrique et/ou un de ses sels
DE102006061829A1 (de) 2006-12-21 2008-06-26 Henkel Kgaa Vorbehandlungsmittel zum Schutz der Kopfhaut
DE102007061970A1 (de) 2007-12-21 2008-07-03 Clariant International Limited Kosmetische, pharmazeutische oder dermatologische Zusammensetzungen enthaltend einen hohen Gehalt an wasserlöslichen Pflegekomponenten
DE102007061969A1 (de) 2007-12-21 2008-07-17 Clariant International Limited Wasserlösliche oder wasserquellbare Polymere auf Basis von Salzen der Acryloyldimethyltaurinsäure oder ihrer Derivate, deren Herstellung und deren Verwendung als Verdicker, Stabilisator und Konsistenzgeber
EP2262469A4 (fr) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc Compositions de soin de la peau et leurs procédés d'utilisation
DE102010011335A1 (de) 2010-03-12 2011-09-15 Beiersdorf Ag Kosmetische Zubereitungen mit hoch-elastischer Textur
EP2575748B1 (fr) * 2010-05-25 2018-04-11 Unilever N.V. Composition d'écran solaire
WO2013012515A1 (fr) 2011-07-19 2013-01-24 Coty Inc. Parfum
ES2396527A1 (es) * 2011-07-19 2013-02-22 Coty Inc. Perfume
ES2461365B1 (es) * 2011-07-19 2015-06-03 Coty Inc. Perfume
CN104023704B (zh) * 2011-10-31 2016-08-17 花王株式会社 化妆品
US8857741B2 (en) 2012-04-27 2014-10-14 Conopco, Inc. Topical spray composition and system for delivering the same
FR2992176B1 (fr) * 2012-06-21 2016-07-01 Oreal Composition cosmetique des particules d'aerogel de silice hydrophobe et un polymere a motif sucre
WO2014062538A1 (fr) 2012-10-19 2014-04-24 3M Innovative Properties Company Hydrogels contenant des polysaccharides, compositions, articles et procédés
JP6208476B2 (ja) * 2013-06-21 2017-10-04 株式会社ディーエイチシー 水中油型化粧料
US20170128357A1 (en) 2015-11-06 2017-05-11 Johnson & Johnson Consumer Inc. Topical gel cream composition
US10543240B2 (en) 2016-12-12 2020-01-28 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
US10206870B2 (en) 2016-12-12 2019-02-19 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
CN111050739A (zh) * 2018-03-30 2020-04-21 株式会社漫丹 凝胶状化妆料
JP6853798B2 (ja) * 2018-03-30 2021-03-31 株式会社マンダム ジェル状化粧料
JP6853846B2 (ja) * 2018-03-30 2021-03-31 株式会社マンダム ジェル状化粧料
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3829610A1 (fr) 2018-07-27 2021-06-09 Johnson & Johnson Surgical Vision, Inc. Compositions et méthodes de traitement de l'oeil
WO2020021481A1 (fr) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions et méthodes de traitement de l'œil
AU2019203692A1 (en) 2018-08-30 2020-03-19 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
CN109575490B (zh) * 2018-11-29 2021-01-26 河海大学 一种透明黏土及其制备方法
KR20200131537A (ko) * 2019-05-14 2020-11-24 (주)아모레퍼시픽 분사 가능한 화장료 조성물 및 화장료
US20220347063A1 (en) * 2019-06-25 2022-11-03 Lv M H Recherche Oil-in-water emulsion gel composition
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP4008305A1 (fr) * 2020-12-07 2022-06-08 Clariant International Ltd Composition huile dans l'eau comprenant des gouttelettes d'huile de diametre de 0,1mm ou plus

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58185514A (ja) * 1982-04-22 1983-10-29 Hisamitsu Pharmaceut Co Inc 新規な局所用消炎鎮痛ゲル状クリ−ム剤
DE3643897A1 (de) * 1986-12-22 1988-06-30 Henkel Kgaa Haarfestlegemittel
NZ243311A (en) * 1991-06-28 1995-02-24 Calgon Corp Composition for treatment of skin and nails which comprises an ampholyte terpolymer comprising non-ionic, cationic and anionic monomers
DE4315405A1 (de) * 1993-05-08 1994-11-10 Wella Ag Haarbehandlungsmittel
FR2706126B1 (fr) * 1993-06-08 1995-07-21 Oreal Composition cosmétique contenant un pseudo-latex ayant des propriétés de rémanence.
DE19531145A1 (de) * 1995-08-24 1997-02-27 Wella Ag Mittel zur Haarbehandlung
DE19702156C1 (de) * 1997-01-22 1998-08-06 Wella Ag Zedernholzöl enthaltende Stylingprodukte
DE19710874C1 (de) * 1997-03-15 1998-08-06 Wella Ag Verwendung natürlicher Öle in Haarbehandlungsmitteln
US5885342A (en) * 1997-05-09 1999-03-23 Engelhard Corporation Blended nacreous pigments, colorants and adjuvants
DE19815461A1 (de) * 1998-04-07 1999-10-14 Wella Ag Flüssige kosmetische Zusammensetzung
DE19820109C2 (de) * 1998-05-06 2000-05-18 Wella Ag Haarbehandlungsmittel mit alpha-Hydroxycarbonsäureestern und Polymeren sowie deren Verwendung
DE19833516C1 (de) * 1998-07-25 2000-02-03 Wella Ag Haarfestigende Mittel mit amphoteren und sauren Polymeren
DE19855097A1 (de) * 1998-11-28 2000-05-31 Wella Ag Pigmenthaltiges, verschäumbares Gel
EP1069142B1 (fr) * 1999-07-15 2010-04-28 Clariant Produkte (Deutschland) GmbH Polymères solubles dans l'eau et leur utilisation dans des produits cosmétiques et pharmaceutiques
DE19934943B4 (de) * 1999-07-26 2007-08-02 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
DE19959119A1 (de) * 1999-12-08 2001-06-13 Clariant Gmbh Emulsionen
DE10000648A1 (de) * 2000-01-11 2001-07-12 Clariant Gmbh Wasserlösliche oder wasserquellbare vernetzte Copolymere

Also Published As

Publication number Publication date
US6620420B2 (en) 2003-09-16
DE50113626D1 (de) 2008-04-03
EP1216686A3 (fr) 2002-07-17
US20020155076A1 (en) 2002-10-24
JP3793798B2 (ja) 2006-07-05
JP2002212022A (ja) 2002-07-31
DE10065047A1 (de) 2002-07-04
EP1216686A2 (fr) 2002-06-26

Similar Documents

Publication Publication Date Title
EP1216686B1 (fr) Gel-crèmes de type émulsion h/e contenant au moins un copolymère acryloyl diméthyltaurate d'ammonium/ vinyl pyrrolidone
EP1216695B1 (fr) Emulsions H/E comprenant un copolymère 2-acrylamido-2-méthyl-propanesulfonate d' ammonium/vinylpyrrolidone
EP0814753B1 (fr) Gels cosmetiques ou dermatologiques a base de microemulsions
EP1731135B1 (fr) Compositions cosmétiques, pharmaceutiques et dermatologiques contenant des cires de homo- et/ou copolymères formée par les monomères éthylene et/ou propylene
DE10141258B4 (de) Kosmetische und dermatologische Zubereitung und ihre Verwendung
EP1681046A2 (fr) Compositions cosmétiques, pharmaceutiques et dermatologiques contenant des cires copolymères
WO2004030644A1 (fr) Emulsion contenant des saccharides substitues
EP1365735A1 (fr) Emulsions eau-huile contenant un ou plusieurs copolymeres d'ammoniumacryloyldimethyltaurate/de vinylpyrrolidone
DE202007018576U1 (de) Kosmetische Zubereitungen mit einem Zusatz aus der Baobabpflanze
WO2003022235A2 (fr) Emulsions eau dans le silicone
EP1269978B1 (fr) Utilisation de dérivés de la bis-resorcinyl triazine dans des préparations cosmétiques ou dermatologiques
DE10327432A1 (de) Bei Entnahme reaktiv aufschäumendes kohlesäurenhaltiges Hautpflegeprodukt
EP1569612B1 (fr) Nouvelle utilisation topique de derives de bis-arylimidazo 1,2-a thiolane
DE10237460A1 (de) Schminkprodukt
EP1216693B1 (fr) Ombre pour paupières contenant au moins un copolymère d'ammoniumacryloyldimethyltaurate/vinylpyrrolidone
EP1529521A2 (fr) Utilisation de glycéride de soja dans des compositions cosmétiques
DE10223694A1 (de) Stabile Emulsion mit einer wässrigen inneren Phase
DE10141683A1 (de) Verwendung von Cyclodextrinen zur Herstellung kosmetischer und dermatologischer Zubereitungen mit verbesserter Verteilbarkeit von anorganischen Pigmenten auf der Haut sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an Cyclodextrinen und anorganischen Pigmenten
EP1477152B1 (fr) Système d'excipient pour agents actifs cosmétiques ou pharmaceutiques
DE102005026004B4 (de) Kosmetische Zubereitungen mit einem Gehalt an einem besonderen Anisfruchtextrakt und höheren Polyolen
DE10252235A1 (de) Emulgatorkombination
DE19903729A1 (de) Verwendung von oberflächenaktiven Citronensäureestern zur Stabilisierung von Retinoiden, synergistische Gemische aus Retinoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE10349678A1 (de) Insekten abwehrende Zubereitung
EP1022055A2 (fr) Compositions de type E/H emulsion contenant une ou plusieurs d'huiles silicones et un ou plusieurs polyisobutènes hydrogénes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 7/48 A, 7A 61K 47/32 B, 7A 61K 7/021 B, 7A 61K 7/032 B

17P Request for examination filed

Effective date: 20021115

AKX Designation fees paid

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17Q First examination report despatched

Effective date: 20040316

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CLARIANT INTERNATIONAL LTD.

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 1/00 20060101ALI20070920BHEP

Ipc: A61Q 17/00 20060101ALI20070920BHEP

Ipc: A61Q 19/00 20060101ALI20070920BHEP

Ipc: A61K 9/107 20060101ALI20070920BHEP

Ipc: A61Q 1/10 20060101ALI20070920BHEP

Ipc: A61K 8/81 20060101ALI20070920BHEP

Ipc: A61Q 1/14 20060101ALI20070920BHEP

Ipc: A61K 8/06 20060101AFI20070920BHEP

Ipc: A61Q 15/00 20060101ALI20070920BHEP

Ipc: A61K 9/00 20060101ALI20070920BHEP

Ipc: A61Q 17/04 20060101ALI20070920BHEP

Ipc: A61K 9/06 20060101ALI20070920BHEP

Ipc: A61Q 1/04 20060101ALI20070920BHEP

Ipc: A61P 17/00 20060101ALI20070920BHEP

Ipc: A61K 47/32 20060101ALI20070920BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB IT

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB IT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REF Corresponds to:

Ref document number: 50113626

Country of ref document: DE

Date of ref document: 20080403

Kind code of ref document: P

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20081121

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20081027

Year of fee payment: 8

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20091112 AND 20091118

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091221

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 50113626

Country of ref document: DE

Representative=s name: MIKULECKY, KLAUS, DIPL.-CHEM. DR.PHIL.NAT., DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 50113626

Country of ref document: DE

Owner name: CLARIANT INTERNATIONAL LTD, CH

Free format text: FORMER OWNER: CLARIANT FINANCE (BVI) LTD., ROAD TOWN, TORTOLA, VG

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20161031

Year of fee payment: 16

Ref country code: FR

Payment date: 20161028

Year of fee payment: 16

Ref country code: GB

Payment date: 20161026

Year of fee payment: 16

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 50113626

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20171221

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180703

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180102

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171221